This transcript provides a critical overview of the diagnosis of fibrosarcoma (FS) in modern soft tissue pathology. Historically defined by a "herringbone fascicular pattern," adult-type fibrosarcoma is now considered vanishingly rare, as modern immunohistochemistry and molecular techniques reclassify most suspected cases as other tumors (e.g., DFSP, synovial sarcoma). The speaker, an experienced soft tissue pathologist, notes that he has never made the diagnosis of adult-type FS, advising the use of "undifferentiated spindle cell sarcoma" instead due to the high statistical likelihood of error. The presentation concludes by outlining the three specific scenarios where the term fibrosarcoma remains appropriate: arising in DFSP, infantile fibrosarcoma (a fusion-positive tumor with good prognosis), and as part of specific named entities.
Fibrosarcoma Diagnosis in Modern Soft Tissue Pathology
0:09 Historical Context: Fibrosarcoma (FS) is a historical term used for sarcomas that exhibited a herringbone fascicular pattern of spindle cells.
0:027 Rarity: Historically, FS was one of the most common sarcomas, but it is now considered "vanishingly rare."
0:30 Modern Reclassification: With modern techniques (immunohistochemistry and molecular workup), most tumors previously diagnosed as FS are now reclassified as other entities (e.g., DFSP, synovial sarcoma, cellular schwannoma, or even melanoma).
1:05 Expert Opinion/Takeaway: Although "adult type fibrosarcoma" is still listed by the WHO, the speaker (a 10-year soft tissue pathologist) has never personally made this diagnosis, preferring to classify uncertain cases as "undifferentiated spindle cell sarcoma" because making the FS diagnosis is statistically likely to be incorrect.
1:47 Acceptable Modern Uses: The term "fibrosarcoma" is appropriate only in three specific circumstances:
1:53 DFSP Component: Fibrosarcoma arising in Dermatofibrosarcoma Protuberans (DFSP).
2:03 Infantile Fibrosarcoma: A rare, translocation-driven sarcoma in babies characterized by the ETV6 and NTRK3 gene fusion. This tumor has a very good prognosis, making accurate diagnosis critical.
2:26 Named Entities: When FS is part of a proper tumor name, such as Low-grade Fibromyxoid Sarcoma or Sclerosing Epithelioid Fibrosarcoma (which are distinct entities, not related to the historical adult-type FS).